| IPO Company Profile |
| SEC Filings | Peer IPO Companies |
| Metalogics, Inc. |
| Riverview Historical Plaza, 33-41 Newark Street, Suite 4-C, Hoboken, NJ 07030 * (201) 656-0906 |
| The company provides enterprise management solutions designed to access the status and interoperability of enterprise-wide computer and microprocessor-embedded systems predominately to the healthcare industry. |
| Manager | Tier | Phone |
| Cruttenden Roth Incorporated | Lead Manager | (800) 678-9147 |
| Barington Capital Group, L.P. | Co-manager | (212) 974-5700 |
| Josephthal Lyon & Ross, Inc. | Co-manager | (212) 907-4545 |
| NASNTL: | ML | High-Tech: | SIC 7372 | |
| Type of Shares: | Common Shares | Filing Date: | 7/30/98 | |
| U.S. Shares Filed: | 2,300,000 | Filing Range: | $11.00 - $13.00 | |
| Non-U.S. Shares Filed: | 0 | Offering Amount: | $27,600,000 | |
| Primary Shares: | 2,300,000 | Expenses: | $500,000 | |
| Secondary Shares: | 0 | Post-IPO Shares: | 6,000,000 | |
| Employees: | 18 |
| Issuer's Law Firm: | Greenberg Traurig Hoffman Lipoff Rosen & Quentel |
| Bank's Law Firm: | Freshman, Marantz, Orlanski, Cooper & Klein |
| Registrar/Transfer Agent: | American Stock Transfer & Trust Co |
| Auditor: | KPMG Peat Marwick |
Dollar amounts in U.S. millions except for per share data | |||||
| 3 Month Ending Financials | |||||
| Full Year Audited Income | Latest Unaudited Income | Prior Audited Income | Balance Sheet | ||
| 12/31/97 | 3/31/98 | 3/31/97 | 3/31/98 | ||
| Revenue: | $1.65 | $0.43 | $0.21 | Assets: | $0.46 |
| Net Income: | -$0.61 | -$0.24 | -$0.06 | Curr Assets: | $0.22 |
| EPS: | -$0.16 | -$0.07 | -$0.02 | Liabilities: | $1.33 |
| Prior EPS: | $0.01 | Curr Liab: | $1.33 | ||
| Cash Flow/Oper: | $0.08 | $0.27 | -$0.01 | Equity: | -$0.87 |
| Cash Flow/Fin: | -$0.07 | Cash: | $0.13 | ||
| Cash Flow/Inv: | -$0.09 | -$0.08 | Working Cap: | -$1.11 | |
| Use of Proceeds |
| The proceeds from the proposed offering will be used to finance current Y2K assessment and expected mitigation projects, to expand sales and marketing, to enhance the company's ongoing product development programs and for working capital and for general corporate purposes. |